 WAYNE, Pa., Nov. 10, 2022 GLOBE NEWSWIRE -- Aclaris Therapeutics, Inc. NASDAQ: ACRS, a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the company will participate in two November healthcare investor conferences. 